Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Journal of Virology|April 24, 2009
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccinesStefania Bellone, Karim El-Sahwi, Emiliano Cocco, et al.
Cancer Medicine|January 10, 2014
Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatmentVinicius Craveiro, Yang Yang-Hartwich, Jennie C Holmberg, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 18, 2015
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitroFrancesca Ferrari, Stefania Bellone, Jonathan Black, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 31, 2018
Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal SarcomaUma Deshmukh, Jonathan Black, Javier Perez-Irizarry, et al.
BMC Cancer|June 23, 2011
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factorEmiliano Cocco, Joyce Varughese, Natalia Buza, et al.
Annals of Surgical Oncology|June 26, 2023
Hyperthermic Intraperitoneal Chemotherapy in Ovarian CancerJulia H Gelissen, Naomi N Adjei, Blair McNamara, et al.
Gynecologic Oncology Reports|February 2, 2018
Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancerBenjamin B Albright, Jonathan D Black, Rachel Passarelli, et al.
Gynecologic and Obstetric Investigation|January 3, 2019
Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and OutcomesJacqueline Feinberg, Benjamin Albright, Jonathan Black, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 15, 2011
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibodyRhoda Raji, Federica Guzzo, Luisa Carrara, et al.
British Journal of Cancer|September 2, 2015
PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomasJonathan D Black, Salvatore Lopez, Emiliano Cocco, et al.
Pageof 15